fr   en
Agreements
Select a partner :
Type of agreement :





Select a compound/Disease :
Choose date:
[<<]      «      7   |   8   |   9   |   10   |   11   |   12   |   13   |   14   |   15   |   16   |   17      »      [65]
Date Partners Compound / Disease area / Development phase Type of agreement Nature / Financial terms
2010-02-04 Genmab (Denmark)
TenX Biopharma (USA)
zanolimumab / cancers licensing
See details
2010-02-03 Edelris (France)
Galapagos (Belgium)
medicinal chemistry optimization services R&D
other
See details
2010-02-02 Novozymes (Denmark)
ProMetic (Canada)
albumin purification technology
AlbuPure® (synthetic-ligand affinity adsorbent) has been developed by ProMetic and Novozymes Biopharma, a subsidiary of Novozymes. It was derived from ProMetic's Mimetic Ligand™ technology and targeted at the capture and purification of recombinant albumin proteins produced in yeast.
marketing/ promotion
other
See details
2010-02-02 Evotec (Germany)
Vifor Pharma (Switzerland)
preclinical candidate / Anaemia R&D
development
other
See details
2010-02-02 TopoTarget (Denmark)
Spectrum Pharmaceuticals (USA)
Belinostat (PXD101 - histone deacetylase inhibitor) / haematological and solid cancers commercialization/ distribution
development
See details
2010-02-02 Orexo (Sweden)
Kyowa Hakko Kirin (Japan)
Hisamitsu Pharmaceutical (Japan)
KW-2246 (sublingual fentanyl product)
The product has been launched in Europe under the brand Abstral®. It is sold in Sweden, UK, Germany, Spain, Greece and France. An NDA has been filed in the US by the partner ProStrakan and in Japan the product is being prepared for registration by the partner Kyowa Hakko Kirin.


/ cancer pain
commercialization/ distribution
See details
2010-02-02 Apeiron Biologics (Austria)
GSK (UK)
APN01 (recombinant human Angiotensin Converting Enzyme 2, rhACE2) / Acute Respiratory Distress Syndrome (ARDS). licensing
See details
2010-02-02 SynCo Bio Partners (The Netherlands)
undisclosed US biopharmaceutical company
two recombinant proteins, to be produced in E. coli.
These products will be manufactured in SynCo’s large-scale GMP facility and take the tally of marketed products manufactured at its Amsterdam facilities to six, since SynCo’s inception in 2000.
manufacturing
See details
2010-02-01
Pierre Fabre SA (France)
Abbott (USA)
h224G11, monoclonal antibody targeting the cMet receptor. cMet protein plays a role in the progression of a range of solid tumors including, prostate, lung and gastric cancers and mediates resistance to chemotherapy.
/ cancer
licensing
commercialization/ distribution
development
See details
2010-02-01 HRA Pharma (France)
Watson Pharmaceuticals (USA)
ulipristal acetate (UPA)
/ emergency contraception
licensing
commercialization/ distribution
See details
2010-01-29 Merus (The Netherlands)
Novartis Option Fund (Switzerland)
oncology program based on bispecific antibodies / cancer R&D
other
See details
2010-01-27 Morphosys (Germany)
Shinogi (Japan)
HuCAL PLATINUM® Antibody Library licensing
other
See details
2010-01-27 Imperial Innovations (UK)
Novartis (Switzerland)
Meningitis B vaccine
This product is based on the work of Professor Christoph Tang’s research group at Imperial College London and collaborator Professor Susan Lea at Oxford University. / Meningitis B
licensing
development
See details
2010-01-26 Celtic Pharma Holdings Advisors LLP (UK)
Cantab BioPharmaceuticals (UK)
PolyTherics (UK)
novel biopharmaceutical molecule / undisclosed R&D
other
See details
2010-01-25 Ipsogen (France)
Consortium of 7 public institutions led by IGR&D, the technology transfer affiliate of
Institut Gustave Roussy (IGR).
(These public institutions are Assistance Publique - Hôpitaux de Paris, Centre de Lutte contre le Cancer Henri Becquerel, Institut Gustave Roussy, INSERM, Université Paris Descartes, Université Paris-Sud 11, Université Pierre et Marie Curie – UPMC).
genomic abnormalities in the TET2 gene (potential biomarker for the management of myeloid disorders) / myeloid disorders licensing
other
See details
[<<]      «      7   |   8   |   9   |   10   |   11   |   12   |   13   |   14   |   15   |   16   |   17      »      [65]